3
Clinical Trials associated with AVI-CO-004Randomized, double-blind, placebo-controlled, dose-increased clinical trials of dose groups to assess safety, tolerability, pharmacokinetics, and pharmacodynamic characteristics after repeated oral administration of AVI-CO-004 for 10 days to male HIV-infected subjects
A dose block-randomized, double blinded, placebo controlled, dose-escalation clinical trial to evaluated the safety, tolerability and pharmacokinetics after multiple oral doses of AVI-CO-004 in healthy male subject
A dose block-randomized, double blinded, placebo controlled, dose-escalation clinical trial to evaluate the safety, tolerability and pharmacokinetics after single oral doses of AVI-CO-004 in healthy male subject
100 Clinical Results associated with AVI-CO-004
100 Translational Medicine associated with AVI-CO-004
100 Patents (Medical) associated with AVI-CO-004
100 Deals associated with AVI-CO-004